Custom Field
Other Name Von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL)
Application IHC-p,ELISA
Reactivity Human
Immunogen The antiserum was produced against synthesized peptide derived from the N-terminal region of human VHL. AA range:1-50
Formulation Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Source Rabbit
Dilution IHC-p 1:50-200, ELISA 1:10000-20000
Concentration 1 mg/ml
Storage -20°C
Stability 1 year